Cambrex

As part of our video series, “A Different Brand of Experts,” we invite you to meet Myoung Goo Kim, Ph.D. and Chemistry R&D Manager at Cambrex in High Point, North Carolina. With more than 20 patent applications, 18 patents and 21 years at Cambrex, Myoung Goo is one of our most accomplished chemists. In his interview, Myoung Goo shares one of the greatest chemistry challenges from his career – a 21-step API process development project with a peptide bond formation. Find out how he optimized this challenging process here: https://lnkd.in/gf2jz_Cr

Välkommen till Sverige! We are excited to be in Stockholm at #BioEurope this week. Stop by booth 50 to connect with Hamid Parsa and Gianluca Di Lernia. #BioPharma #ConnectWithCambrex

This Fall our sites have continued to be active within their communities. Our High Point, NC site partnered with BackPack Beginnings to gather donations for their Family Market providing resources to children and families in their community. The Snapdragon Chemistry team participated in the Cambridge Science Festival with their "Glowing with the Flow" demonstrations. The Agawam, MA site partnered with the Salvation Army collecting boxes full of cold weather gear for children and adults. In Durham, NC teams created 140 blankets for Fleece & Thank You to be distributed to multiple children's hospitals. In addition, our sites in North Carolina are working together for a Hurricane Helene Donation Drive collecting coats, scarves, hats, gloves, and blankets to deliver to our neighbors in Western North Carolina. 

Our Scientific Experts took time away from the lab to attend events and share what they have been working on. We presented at #CMF2024, #PDAMicro, Shimadzu Pharma Summit, and the Q1 Scientific Stability Studies Conference. Last month, we brought together 70 of our experts from across Cambrex's global sites at our inaugural Cambrex Science Day, promoting collaborative learning and scientific excellence. Additionally, Analytical Scientists from Durham, NC traveled to our Charles City, IA site to discuss their cross-site projects. We also exhibited at #NLSDays, #CPHIMilan, and the #NESACS Process Chemistry Symposium.   Looking forward to the remainder of the year!

We are thrilled to be exhibiting at #TIDESEurope next month! Both the Cambrex and Snapdragon Chemistry teams are looking forward to meeting you in Hamburg! Click here to schedule a meeting with Eric Fang, Andy Miles, and Seamus White. https://lnkd.in/gqxkuMi9 #Peptides #ConnectWithCambrex

While automation in the development of small molecule APIs is not a new concept, the continuous advancement of technology has yielded benefits across all stages of development and manufacturing. David Ford, Senior Director of Chemistry at Snapdragon Chemistry, a Cambrex company, recently discussed these benefits with Pharmaceutical Technology Magazine. Read the full article here: https://lnkd.in/eiGMvyTM

What do oncologics and orphan drugs have in common? Both can potentially require low-volume production assets and specialized technologies for the manufacturing of active ingredients. In a recent article published by Specialty Chemicals Magazine, Dan Bowles, VP and General Manager at Cambrex in High Point, North Carolina, discusses the process development and manufacturing challenges associated with low-volume API production. Read the full article here: https://lnkd.in/eaqjCB8t

As part of our video series, “A Different Brand of Experts,” we invite you to meet Jonas Nilsson, Ph.D. and Principal Scientist in Karlskoga, Sweden. Jonas is a career chemist who has been at Cambrex for nearly 20 years. He specializes in process development and optimization for new clients beginning the tech transfer of phase II or early phase III assets.  We asked Jonas to describe how his team approaches technology transfers, and he shared, "Every project has its core team with an engineer, analytical chemist, project manager, chemist, and QA representative. That team stays together right through the transfer process from R&D to production, and if applicable, through validation and commercialization. Every chemist takes pride in making the best effort to meet and exceed customer expectations to generate add-on value.” Read his full interview here: https://lnkd.in/eXPgr7PR

At Cambrex and Snapdragon Chemistry, we believe in a science-forward approach to drug development. In practice, that means ensuring that our technical teams take time to innovate and collaborate on their breakthroughs. Last month, we brought together 70 of our experts from across Cambrex's global sites to share their scientific achievements at our inaugural Cambrex Science Day. From Longmont to Liège, Milan to Massachusetts, and Edinburgh to Estonia, knowledge sharing is critical to delivering our science-forward commitment to clients and patients. 

Developing and manufacturing peptide-based therapies can be both scientifically and financially challenging. We invite you to join our upcoming webinar for a scientific deep dive on Cambrex's liquid-phase peptide synthesis technology, which significantly reduces solvent demand and the need for excess reagents compared to standard solid-state peptide synthesis processes. Register here: https://lnkd.in/ewxcAxHf